Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis
- Resource Type
- Article
- Source
- In
Matrix Biology August 2022 111:189-206 - Subject
- Language
- ISSN
- 0945-053X